申请人:CRYSTAL PHARMA, S.A.U.
公开号:US20160229885A1
公开(公告)日:2016-08-11
The invention relates to a process for obtaining Estetrol or a salt or solvate thereof, the process comprising: a) reacting a compound of formula (IV) or a salt or solvate thereof, wherein R
1
is a hydroxyl protecting group selected from a silyl ether, an ether, an ester, a carbamate and a carbonate, and R
2
is a hydroxyl protecting group selected from an ether, with an oxidizing agent selected from OsO
4
or a source of osmium tetroxide to produce Estetrol or a compound of formula (II) or a salt or solvate thereof wherein R
1
is as defined previously; and b) if a compound of formula (II) is obtained in step a), deprotecting said compound to produce Estetrol.